2016
DOI: 10.1373/clinchem.2014.234708
|View full text |Cite
|
Sign up to set email alerts
|

Milky Pleural Fluid

Abstract: A 90-year-old man was admitted for progressive dyspnea. His medical history included hypertension and chronic myeloid leukemia diagnosed 10 years before and treated with dasatinib. Physical examination revealed pitting edema of the legs and dullness to percussion in the right chest. Laboratory test results were clinically relevant for white blood cells 7.7 ϫ 10 9 /L (reference interval 4 -10 ϫ 10 9 /L), platelets 162 ϫ 10 9 /L (150 -400 ϫ 10 9 /L), hemoglobin 10.5 g/dL (13-18 g/dL), total protein 7.1 g/dL Afte… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0
1

Year Published

2017
2017
2020
2020

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 9 publications
0
1
0
1
Order By: Relevance
“…Although dasatinib-induced pleural effusion has been frequently reported in patients receiving treatment with TKIs for CML (26 of 258; 10.1%) (1), dasatinib-related chylothorax is a rare complication. To the best of our knowledge, only eight cases of this adverse event have previously been reported (Table) (2-4,9,10), and no article reporting chylothorax associated with other TKIs (imatinib, nilotinib, or bosutinib) is available. Although the main causes of chylothorax have been identified to include trauma, thoracic surgery, tuberculosis, amyloidosis, and malignant neoplasm (11), the pathophysiology of dasatinib-related chylothorax has not yet been fully characterized.…”
Section: Discussionmentioning
confidence: 99%
“…Although dasatinib-induced pleural effusion has been frequently reported in patients receiving treatment with TKIs for CML (26 of 258; 10.1%) (1), dasatinib-related chylothorax is a rare complication. To the best of our knowledge, only eight cases of this adverse event have previously been reported (Table) (2-4,9,10), and no article reporting chylothorax associated with other TKIs (imatinib, nilotinib, or bosutinib) is available. Although the main causes of chylothorax have been identified to include trauma, thoracic surgery, tuberculosis, amyloidosis, and malignant neoplasm (11), the pathophysiology of dasatinib-related chylothorax has not yet been fully characterized.…”
Section: Discussionmentioning
confidence: 99%
“…Pré-bêta-LP Comme précisé dans le tableau 3, la coloration au Fat Red 7B conduit à un gain de temps technique (environ 40 min) pour les phases de séchage du gel et de coloration/décoloration, ce qui permet de répondre plus rapidement (en moins de 3 h) à certaines demandes urgentes (en particulier, recherche de chylomicrons dans un liquide pleural afin de poser un diagnostic de chylothorax au décours d'une intervention chirurgicale [6]), notamment pour des services pédiatriques. Toutefois, peu de laboratoires disposent de la technique du lipoprotéinogramme qui constitue le « gold standard » pour le diagnostic d'un chylothorax dans un liquide de plèvre ; une orientation diagnostique peut être basée sur l'aspect du liquide après 12 h à 4 • C (présence d'une couche de chylomicrons surnageante), la concentration des protéines et l'activité de la lactate deshydrogénase (80 % des chylomicrons sont des exsudats), ainsi que les concentrations du cholestérol (< 5 mmol/L) et des triglycérides (> 1,25 mmol/L) [7][8][9].…”
unclassified